ISOOR INSIGHT TEAM. Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025. Journal of Organoid and Bioscience, [S. l.], v. 3, n. 1, 2026. Disponível em: https://jobs.isoor.org/index.php/journal/article/view/57. Acesso em: 3 mar. 2026.